"prostate tumor progression" trang 3 - tải miễn phí từ tailieunhanh
Prognostic value of the bone scan index in patients with metastatic castration-resistant prostate cancer: A systematic review and meta-analysis

Prognostic value of the bone scan index in patients with metastatic castration-resistant prostate cancer: A systematic review and meta-analysis
7    81    0
A novel tetrapeptide fluorescence sensor for early diagnosis of prostate cancer based on imaging Zn2+ in healthy versus cancerous cells

A novel tetrapeptide fluorescence sensor for early diagnosis of prostate cancer based on imaging Zn2+ in healthy versus cancerous cells
8    74    0
Could aspirin be a lifesaver for prostate cancer patients in prostate cancer-specific mortality?: An update systematic review and meta-analysis

Could aspirin be a lifesaver for prostate cancer patients in prostate cancer-specific mortality?: An update systematic review and meta-analysis
8    58    0
A phase II randomized placebo-controlled double-blind study of salvage radiation therapy plus placebo versus SRT plus enzalutamide with high-risk PSA-recurrent prostate cancer after radical prostatectomy (SALV-ENZA)

A phase II randomized placebo-controlled double-blind study of salvage radiation therapy plus placebo versus SRT plus enzalutamide with high-risk PSA-recurrent prostate cancer after radical prostatectomy (SALV-ENZA)
10    80    1
High-level expression of protein tyrosine phosphatase non-receptor 12 is a strong and independent predictor of poor prognosis in prostate cancer

High-level expression of protein tyrosine phosphatase non-receptor 12 is a strong and independent predictor of poor prognosis in prostate cancer
12    68    0
Treatment in the STAMPEDE era for castrate resistant prostate cancer in the UK: ongoing challenges and underappreciated clinical problems

Treatment in the STAMPEDE era for castrate resistant prostate cancer in the UK: ongoing challenges and underappreciated clinical problems
10    58    1
Usefulness of combined androgen blockade therapy with gonadotropinreleasing hormone antagonist for bone metastatic prostate cancer with pretreatment prostate-specific antigen level ≥ 50 ng/mL

Usefulness of combined androgen blockade therapy with gonadotropinreleasing hormone antagonist for bone metastatic prostate cancer with pretreatment prostate-specific antigen level ≥ 50 ng/mL
11    75    1
PSCA expression is associated with favorable tumor features and reduced PSA recurrence in operated prostate cancer

PSCA expression is associated with favorable tumor features and reduced PSA recurrence in operated prostate cancer
9    54    1
Safety and efficacy of abiraterone acetate in chemotherapy-naive patients with metastatic castration-resistant prostate cancer: An Italian multicenter “real life” study

Safety and efficacy of abiraterone acetate in chemotherapy-naive patients with metastatic castration-resistant prostate cancer: An Italian multicenter “real life” study
8    31    1
The values of neutrophil-lymphocyte ratio and/or prostate-specific antigen in discriminating real Gleason score ≥ 7 prostate cancer from group of biopsybased Gleason score ≤ 6

The values of neutrophil-lymphocyte ratio and/or prostate-specific antigen in discriminating real Gleason score ≥ 7 prostate cancer from group of biopsybased Gleason score ≤ 6
8    31    1
Stress alters the expression of cancerrelated genes in the prostate

Stress alters the expression of cancerrelated genes in the prostate
10    60    1
Men’s perceptions of prostate cancer diagnosis and care: Insights from qualitative interviews in Victoria, Australia

Men’s perceptions of prostate cancer diagnosis and care: Insights from qualitative interviews in Victoria, Australia
12    82    1
Design of the PROstate cancer follow-up care in Secondary and Primary hEalth Care study (PROSPEC): A randomized controlled trial to evaluate the effectiveness of primary care-based follow-up of localized prostate cancer survivors

Design of the PROstate cancer follow-up care in Secondary and Primary hEalth Care study (PROSPEC): A randomized controlled trial to evaluate the effectiveness of primary care-based follow-up of localized prostate cancer survivors
10    76    1
Six transmembrane epithelial antigen of prostate (STEAP1) Immunohistochemical expression in neoplastic and non-neoplastic epithelial lesion of prostate

Six transmembrane epithelial antigen of prostate (STEAP1) Immunohistochemical expression in neoplastic and non-neoplastic epithelial lesion of prostate
13    67    1
The transverse and vertical distribution of prostate cancer in biopsy and radical prostatectomy specimens

The transverse and vertical distribution of prostate cancer in biopsy and radical prostatectomy specimens
6    90    1
The efficacy and toxicity of cabazitaxel for treatment of docetaxel-resistant prostate cancer correlating with the initial doses in Japanese patients

The efficacy and toxicity of cabazitaxel for treatment of docetaxel-resistant prostate cancer correlating with the initial doses in Japanese patients
7    48    1
Reduced FRG1 expression promotes prostate cancer progression and affects prostate cancer cell migration and invasion

Reduced FRG1 expression promotes prostate cancer progression and affects prostate cancer cell migration and invasion
15    52    1
Is a retrovirus (XMRV) risk factor for prostate cancer in Indian population

Is a retrovirus (XMRV) risk factor for prostate cancer in Indian population
11    70    1
Epithelial cell adhesion molecule (EpCAM) is involved in prostate cancer chemotherapy/radiotherapy response in vivo

Epithelial cell adhesion molecule (EpCAM) is involved in prostate cancer chemotherapy/radiotherapy response in vivo
12    42    1
Immune landscape of human prostate cancer: Immune evasion mechanisms and biomarkers for personalized immunotherapy

Immune landscape of human prostate cancer: Immune evasion mechanisms and biomarkers for personalized immunotherapy
10    64    1